| Entry |
|
|---|
| Name |
Reviparin sodium (JAN);
Clivarine (TN)
|
|---|
| Activity |
Anticoagulant;
Antithrombotic
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Comment |
Low molecular weight heparin (LMWH)
|
|---|
| Target |
antithrombin III activator [HSA: 462] [KO: K03911] |
|---|
| Pathway |
hsa04610 Complement and coagulation cascades | |
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3334 Heparins
D03337 Reviparin sodium (JAN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AB Heparin group
B01AB08 Reviparin
D03337 Reviparin sodium (JAN)
Target-based classification of drugs [BR:br08310]
Others
Heparin binding proteins
antithrombin III [HSA:462] [KO:K03911]
Reviparin [ATC:B01AB08]
D03337 Reviparin sodium (JAN)
 |
|---|
| Other DBs |
CAS: 9041-08-1 PubChem: NIKKAJI: |
|---|
